阿尼卡治療公司
DE ˙ DB ˙ US0352551081
€11.90 0.00 (0.00%)
2026-06-04
分享價格
SecurityDE:AKP / Anika Therapeutics, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership70,506 shares
Latest Disclosed Value $ 677,563
Barclays Plc ownership in AKP / Anika Therapeutics, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 70,506 shares of Anika Therapeutics, Inc. (DE:AKP) valued at $564,048 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 32,074 shares of Anika Therapeutics, Inc.. This represents a change in shares of 119.82% during the quarter. The current value of the position is $839,021 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (AKP) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:AKP / Anika Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F ANIKA THERAPEUTICS COM 035255108 70,506 38,432 119.82 678 124.92 0.0002
2026-03-31 2025-09-30 13F/A-3 ANIKA THERAPEUTICS COM 035255108 32,074 -3,316 -9.37 301 -19.52 0.0001
2026-03-19 2025-09-30 13F/A-2 ANIKA THERAPEUTICS COM 035255108 32,664 -2,726 807 0.0002
2025-11-12 2025-09-30 13F ANIKA THERAPEUTICS COM 035255108 32,074 -3,316 301 0.0001
2026-02-27 2025-06-30 13F/A-2 ANIKA THERAPEUTICS COM 035255108 35,390 7,379 26.34 374 -11.16 0.0001
2025-08-14 2025-06-30 13F/A-1 ANIKA THERAPEUTICS COM 035255108 35,390 7,379 0 0.0001
2025-08-13 2025-06-30 13F ANIKA THERAPEUTICS COM 035255108 35,390 7,379 0 0.0000
2026-03-17 2025-03-31 13F/A-1 ANIKA THERAPEUTICS COM 035255108 28,011 -6,746 -19.41 421 -26.40 0.0001
2025-05-15 2025-03-31 13F ANIKA THERAPEUTICS COM 035255108 28,011 -6,746 0 0.0001
2026-03-19 2024-12-31 13F/A-1 ANIKA THERAPEUTICS COM 035255108 34,757 2,093 6.41 572 -29.03 0.0002
2025-02-13 2024-12-31 13F ANIKA THERAPEUTICS COM 035255108 34,757 2,093 1 0.0002
2026-03-31 2024-09-30 13F/A-2 ANIKA THERAPEUTICS COM 035255108 32,664 13,054 66.57 807 62.50 0.0002
2024-11-19 2024-09-30 13F/A-1 ANIKA THERAPEUTICS COM 035255108 32,664 13,054 1 0.0002
2024-11-15 2024-09-30 13F ANIKA THERAPEUTICS COM 035255108 32,664 13,054 1 0.0001
2026-03-23 2024-06-30 13F/A-1 ANIKA THERAPEUTICS COM 035255108 19,610 -8,244 -29.60 497 -29.84 0.0002
2024-08-14 2024-06-30 13F ANIKA THERAPEUTICS COM 035255108 19,610 -8,244 0 0.0002
2026-03-24 2024-03-31 13F/A-1 ANIKA THERAPEUTICS COM 035255108 27,854 -9,972 -26.36 707 -17.50 0.0002
2024-05-15 2024-03-31 13F ANIKA THERAPEUTICS COM 035255108 27,854 -9,972 1 0.0002
2026-03-25 2023-12-31 13F/A-1 ANIKA THERAPEUTICS COM 035255108 37,826 11,061 41.33 857 72.09 0.0003
2024-02-15 2023-12-31 13F ANIKA THERAPEUTICS COM 035255108 37,826 11,061 1 0.0003
2026-03-26 2023-09-30 13F/A-1 ANIKA THERAPEUTICS COM 035255108 26,765 2,209 9.00 499 -21.82 0.0003
2023-11-07 2023-09-30 13F ANIKA THERAPEUTICS COM 035255108 26,765 2,209 0 0.0003
2026-03-30 2023-06-30 13F/A-2 ANIKA THERAPEUTICS COM 035255108 24,556 3,988 19.39 638 7.97 0.0004
2023-09-20 2023-06-30 13F/A-1 ANIKA THERAPEUTICS COM 035255108 24,556 3,988 1 0.0004
2023-08-03 2023-06-30 13F ANIKA THERAPEUTICS COM 035255108 24,556 3,988 1 0.0004
2026-03-30 2023-03-31 13F/A-1 ANIKA THERAPEUTICS COM 035255108 20,568 -4,405 -17.64 591 -20.16 0.0003
2023-05-04 2023-03-31 13F ANIKA THERAPEUTICS COM 035255108 20,568 -4,405 1 0.0003
2026-03-30 2022-12-31 13F/A-1 ANIKA THERAPEUTICS COM 035255108 24,973 -340 -1.34 739 22.76 0.0003
2023-02-13 2022-12-31 13F ANIKA THERAPEUTICS COM 035255108 24,973 -340 1 0.0003
2022-11-03 2022-09-30 13F ANIKA THERAPEUTICS COM 035255108 25,313 20,771 457.31 602 496.04 0.0007
2022-08-12 2022-06-30 13F ANIKA THERAPEUTICS COM 035255108 4,542 -7,105 -61.00 101 -65.53 0.0001
2022-05-16 2022-03-31 13F ANIKA THERAPEUTICS COM 035255108 11,647 -7,199 -38.20 293 -56.66 0.0002
2022-02-23 2021-12-31 13F/A-1 ANIKA THERAPEUTICS COM 035255108 18,846 6,193 48.94 676 25.65 0.0003
2022-02-14 2021-12-31 13F ANIKA THERAPEUTICS COM 035255108 18,846 6,193 676 0.0001
2021-11-09 2021-09-30 13F ANIKA THERAPEUTICS COM 035255108 12,653 3,667 40.81 538 38.30 0.0002
2021-08-13 2021-06-30 13F ANIKA THERAPEUTICS COM 035255108 8,986 -18,551 -67.37 389 -65.39 0.0002
2021-05-13 2021-03-31 13F ANIKA THERAPEUTICS COM 035255108 27,537 3,807 16.04 1,124 4.66 0.0006
2021-02-11 2020-12-31 13F ANIKA THERAPEUTICS COM 035255108 23,730 -5,645 -19.22 1,074 3.47 0.0006
2020-11-12 2020-09-30 13F ANIKA THERAPEUTICS COM 035255108 29,375 4,897 20.01 1,038 12.34 0.0006
2020-08-12 2020-06-30 13F ANIKA THERAPEUTICS COM 035255108 24,478 10,339 73.12 924 125.92 0.0007
2020-05-13 2020-03-31 13F ANIKA THERAPEUTICS COM 035255108 14,139 -13,694 -49.20 409 -71.64 0.0003
2020-02-10 2019-12-31 13F ANIKA THERAPEUTICS COM 035255108 27,833 -7,332 -20.85 1,442 -25.28 0.0008
2019-11-15 2019-09-30 13F/A-1 ANIKA THERAPEUTICS COM 035255108 35,165 3,366 10.59 1,930 49.38 0.0012
2019-11-14 2019-09-30 13F ANIKA THERAPEUTICS COM 035255108 35,165 3,366 1,930 446.2182
2019-08-14 2019-06-30 13F ANIKA THERAPEUTICS COM 035255108 31,799 15,092 90.33 1,292 155.34 0.0008
2019-05-15 2019-03-31 13F ANIKA THERAPEUTICS COM 035255108 16,707 10,216 157.39 506 131.05 0.0003
2019-02-14 2018-12-31 13F ANIKA THERAPEUTICS COM 035255108 6,491 -14,216 -68.65 219 -74.89 0.0002
2018-11-14 2018-09-30 13F ANIKA THERAPEUTICS COM 035255108 20,707 12,008 138.04 872 212.54 0.0006
2018-08-14 2018-06-30 13F ANIKA THERAPEUTICS COM 035255108 8,699 -20,394 -70.10 279 -80.72 0.0002
2018-05-15 2018-03-31 13F ANIKA THERAPEUTICS COM 035255108 29,093 -4,671 -13.83 1,447 -20.49 0.0011
2018-02-14 2017-12-31 13F ANIKA THERAPEUTICS COM 035255108 33,764 4,482 15.31 1,820 7.18 0.0015
2017-11-14 2017-09-30 13F ANIKA THERAPEUTICS COM 035255108 29,282 -5,579 -16.00 1,698 -1.34 0.0017
2017-08-14 2017-06-30 13F ANIKA THERAPEUTICS COM 035255108 34,861 15,559 80.61 1,721 105.13 0.0018
2017-05-15 2017-03-31 13F ANIKA THERAPEUTICS COM 035255108 19,302 12,483 183.06 839 151.95 0.0009
2017-02-14 2016-12-31 13F ANIKA THERAPEUTICS COM 035255108 6,819 -18,769 -73.35 333 -72.79 0.0004
2016-11-14 2016-09-30 13F ANIKA THERAPEUTICS COM 035255108 25,588 -1,539 -5.67 1,224 -15.88 0.0014
2016-08-12 2016-06-30 13F ANIKA THERAPEUTICS COM 035255108 27,127 -13,091 -32.55 1,455 -17.80 0.0019
2016-05-16 2016-03-31 13F ANIKA THERAPEUTICS COM 035255108 40,218 718 1.82 1,770 17.92 0.0027
2016-02-12 2015-12-31 13F ANIKA THERAPEUTICS COM 035255108 39,500 20,723 110.36 1,501 157.90 0.0018
2015-11-13 2015-09-30 13F ANIKA THERAPEUTICS COM 035255108 18,777 7,298 63.58 582 53.97 0.0007
2015-08-14 2015-06-30 13F ANIKA THERAPEUTICS COM 035255108 11,479 11,044 2,538.85 378 2,000.00 0.0004
2015-05-19 2015-03-31 13F/A-1 ANIKA THERAPEUTICS COM 035255108 435 -387 -47.08 18 -45.45 0.0000
2015-05-14 2015-03-31 13F ANIKA THERAPEUTICS COM 035255108 435 18
2015-02-13 2014-12-31 13F ANIKA THERAPEUTICS COM 035255108 822 -789 -48.98 33 -43.10 0.0000
2014-11-14 2014-09-30 13F ANIKA THERAPEUTICS COM 035255108 1,611 -4,319 -72.83 58 -78.68 0.0001
2014-08-14 2014-06-30 13F ANIKA THERAPEUTICS COM 035255108 5,930 2,629 79.64 272 101.48 0.0003
2014-05-15 2014-03-31 13F ANIKA THERAPEUTICS COM 035255108 3,301 93 2.90 135 10.66 0.0002
2014-02-13 2013-12-31 13F ANIKA THERAPEUTICS COM 035255108 3,208 -848 -20.91 122 31.18 0.0001
2013-11-14 2013-09-30 13F ANIKA THERAPEUTICS COM 035255108 4,056 1,777 77.97 93 144.74 0.0001
2013-08-14 2013-06-30 13F ANIKA THERAPEUTICS COM 035255108 2,279 2,279 38 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-02-13 2013-12-31 13F ANIKA THERAPEUTICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2013-11-14 2013-09-30 13F ANIKA THERAPEUTICS OPT Call 120,000 2,760 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.